TD2 PRECISION ONCOLOGY Trademark
Trademark Overview
On Wednesday, January 12, 2022, a trademark application was filed for TD2 PRECISION ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the TD2 PRECISION ONCOLOGY trademark a serial number of 97215981. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by TRANSLATIONAL DRUG DEVELOPMENT, LLC. The TD2 PRECISION ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses in the field of oncology; Scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; Providing scientific research information in the field of pre-clinical testing; Pharmaceutical drug development and related services, namely, pharmaceutical products development and pharmaceutical research services
General Information
| Serial Number | 97215981 |
| Word Mark | TD2 PRECISION ONCOLOGY |
| Filing Date | Wednesday, January 12, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 22, 2023 |
| Registration Number | 7141897 |
| Registration Date | Tuesday, August 22, 2023 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 6, 2023 |
Trademark Statements
| Description of Mark | The mark consists of the words "TD2" with a symbol formed by circles of various sizes overlapping and sweeping to the left above the words "PRECISION ONCOLOGY". |
| Pseudo Mark | TRANSLATIONAL DRUG TWO PRECISION ONCOLOGY; TRANSLATIONAL DRUG TO PRECISION ONCOLOGY |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "PRECISION ONCOLOGY" |
| Goods and Services | Consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses in the field of oncology; Scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; Providing scientific research information in the field of pre-clinical testing; Pharmaceutical drug development and related services, namely, pharmaceutical products development and pharmaceutical research services |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 19, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, December 10, 2021 |
| First Use In Commerce Date | Friday, December 10, 2021 |
Trademark Owner History
| Party Name | TRANSLATIONAL DRUG DEVELOPMENT, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Scottsdale, AZ 85259 |
| Party Name | TRANSLATIONAL DRUG DEVELOPMENT, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Scottsdale, AZ 85259 |
| Party Name | TRANSLATIONAL DRUG DEVELOPMENT, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Scottsdale, AZ 85259 |
Trademark Events
| Event Date | Event Description |
| Saturday, January 15, 2022 | NEW APPLICATION ENTERED |
| Wednesday, January 19, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 20, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, October 19, 2022 | ASSIGNED TO EXAMINER |
| Monday, October 24, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, October 24, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, October 24, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 7, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, April 8, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 17, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 6, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 6, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 22, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 22, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Thursday, July 24, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, July 24, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, July 24, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
